| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 23:31:40 UTC |
|---|
| Update Date | 2021-09-26 22:55:39 UTC |
|---|
| HMDB ID | HMDB0246510 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 4-Methylhistamine |
|---|
| Description | 4-Methylhistamine belongs to the class of organic compounds known as 2-arylethylamines. These are primary amines that have the general formula RCCNH2, where R is an organic group. 4-Methylhistamine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on 4-Methylhistamine. This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-methylhistamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-Methylhistamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | InChI=1S/C6H11N3/c1-5-6(2-3-7)9-4-8-5/h4H,2-3,7H2,1H3,(H,8,9) |
|---|
| Synonyms | | Value | Source |
|---|
| 5-Methylhistamine | ChEBI | | 4-Methylhistamine dihydrochloride | HMDB | | 4-Methylhistamine hydride | HMDB |
|
|---|
| Chemical Formula | C6H11N3 |
|---|
| Average Molecular Weight | 125.175 |
|---|
| Monoisotopic Molecular Weight | 125.095297366 |
|---|
| IUPAC Name | 2-(5-methyl-1H-imidazol-4-yl)ethan-1-amine |
|---|
| Traditional Name | 4-methylhistamine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C(CCN)N=CN1 |
|---|
| InChI Identifier | InChI=1S/C6H11N3/c1-5-6(2-3-7)9-4-8-5/h4H,2-3,7H2,1H3,(H,8,9) |
|---|
| InChI Key | UGYXPZQILZRKJJ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 2-arylethylamines. These are primary amines that have the general formula RCCNH2, where R is an organic group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic nitrogen compounds |
|---|
| Class | Organonitrogen compounds |
|---|
| Sub Class | Amines |
|---|
| Direct Parent | 2-arylethylamines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 2-arylethylamine
- Aralkylamine
- Heteroaromatic compound
- Imidazole
- Azole
- Azacycle
- Organoheterocyclic compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary aliphatic amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 7.7217 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.95 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 342.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 269.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 54.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 179.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 62.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 276.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 225.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 927.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 507.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 33.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 527.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 182.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 276.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 793.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 658.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 351.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 4-Methylhistamine,1TMS,isomer #1 | CC1=C(CCN[Si](C)(C)C)N=C[NH]1 | 1536.3 | Semi standard non polar | 33892256 | | 4-Methylhistamine,1TMS,isomer #1 | CC1=C(CCN[Si](C)(C)C)N=C[NH]1 | 1555.6 | Standard non polar | 33892256 | | 4-Methylhistamine,1TMS,isomer #1 | CC1=C(CCN[Si](C)(C)C)N=C[NH]1 | 1960.7 | Standard polar | 33892256 | | 4-Methylhistamine,1TMS,isomer #2 | CC1=C(CCN)N=CN1[Si](C)(C)C | 1527.6 | Semi standard non polar | 33892256 | | 4-Methylhistamine,1TMS,isomer #2 | CC1=C(CCN)N=CN1[Si](C)(C)C | 1492.0 | Standard non polar | 33892256 | | 4-Methylhistamine,1TMS,isomer #2 | CC1=C(CCN)N=CN1[Si](C)(C)C | 2121.2 | Standard polar | 33892256 | | 4-Methylhistamine,2TMS,isomer #1 | CC1=C(CCN[Si](C)(C)C)N=CN1[Si](C)(C)C | 1657.7 | Semi standard non polar | 33892256 | | 4-Methylhistamine,2TMS,isomer #1 | CC1=C(CCN[Si](C)(C)C)N=CN1[Si](C)(C)C | 1672.6 | Standard non polar | 33892256 | | 4-Methylhistamine,2TMS,isomer #1 | CC1=C(CCN[Si](C)(C)C)N=CN1[Si](C)(C)C | 1860.8 | Standard polar | 33892256 | | 4-Methylhistamine,2TMS,isomer #2 | CC1=C(CCN([Si](C)(C)C)[Si](C)(C)C)N=C[NH]1 | 1798.1 | Semi standard non polar | 33892256 | | 4-Methylhistamine,2TMS,isomer #2 | CC1=C(CCN([Si](C)(C)C)[Si](C)(C)C)N=C[NH]1 | 1754.0 | Standard non polar | 33892256 | | 4-Methylhistamine,2TMS,isomer #2 | CC1=C(CCN([Si](C)(C)C)[Si](C)(C)C)N=C[NH]1 | 1928.3 | Standard polar | 33892256 | | 4-Methylhistamine,3TMS,isomer #1 | CC1=C(CCN([Si](C)(C)C)[Si](C)(C)C)N=CN1[Si](C)(C)C | 1920.8 | Semi standard non polar | 33892256 | | 4-Methylhistamine,3TMS,isomer #1 | CC1=C(CCN([Si](C)(C)C)[Si](C)(C)C)N=CN1[Si](C)(C)C | 1860.2 | Standard non polar | 33892256 | | 4-Methylhistamine,3TMS,isomer #1 | CC1=C(CCN([Si](C)(C)C)[Si](C)(C)C)N=CN1[Si](C)(C)C | 1850.4 | Standard polar | 33892256 | | 4-Methylhistamine,1TBDMS,isomer #1 | CC1=C(CCN[Si](C)(C)C(C)(C)C)N=C[NH]1 | 1801.9 | Semi standard non polar | 33892256 | | 4-Methylhistamine,1TBDMS,isomer #1 | CC1=C(CCN[Si](C)(C)C(C)(C)C)N=C[NH]1 | 1788.8 | Standard non polar | 33892256 | | 4-Methylhistamine,1TBDMS,isomer #1 | CC1=C(CCN[Si](C)(C)C(C)(C)C)N=C[NH]1 | 2071.2 | Standard polar | 33892256 | | 4-Methylhistamine,1TBDMS,isomer #2 | CC1=C(CCN)N=CN1[Si](C)(C)C(C)(C)C | 1774.5 | Semi standard non polar | 33892256 | | 4-Methylhistamine,1TBDMS,isomer #2 | CC1=C(CCN)N=CN1[Si](C)(C)C(C)(C)C | 1683.0 | Standard non polar | 33892256 | | 4-Methylhistamine,1TBDMS,isomer #2 | CC1=C(CCN)N=CN1[Si](C)(C)C(C)(C)C | 2180.0 | Standard polar | 33892256 | | 4-Methylhistamine,2TBDMS,isomer #1 | CC1=C(CCN[Si](C)(C)C(C)(C)C)N=CN1[Si](C)(C)C(C)(C)C | 2141.9 | Semi standard non polar | 33892256 | | 4-Methylhistamine,2TBDMS,isomer #1 | CC1=C(CCN[Si](C)(C)C(C)(C)C)N=CN1[Si](C)(C)C(C)(C)C | 2073.2 | Standard non polar | 33892256 | | 4-Methylhistamine,2TBDMS,isomer #1 | CC1=C(CCN[Si](C)(C)C(C)(C)C)N=CN1[Si](C)(C)C(C)(C)C | 2044.6 | Standard polar | 33892256 | | 4-Methylhistamine,2TBDMS,isomer #2 | CC1=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C[NH]1 | 2228.0 | Semi standard non polar | 33892256 | | 4-Methylhistamine,2TBDMS,isomer #2 | CC1=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C[NH]1 | 2171.6 | Standard non polar | 33892256 | | 4-Methylhistamine,2TBDMS,isomer #2 | CC1=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C[NH]1 | 2092.5 | Standard polar | 33892256 | | 4-Methylhistamine,3TBDMS,isomer #1 | CC1=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN1[Si](C)(C)C(C)(C)C | 2546.5 | Semi standard non polar | 33892256 | | 4-Methylhistamine,3TBDMS,isomer #1 | CC1=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN1[Si](C)(C)C(C)(C)C | 2453.9 | Standard non polar | 33892256 | | 4-Methylhistamine,3TBDMS,isomer #1 | CC1=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN1[Si](C)(C)C(C)(C)C | 2158.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 4-Methylhistamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0032-9200000000-bc9882056b1d71bcffa5 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Methylhistamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Methylhistamine 10V, Positive-QTOF | splash10-0a4i-1900000000-d7d5b56185b8e29b9ae4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Methylhistamine 20V, Positive-QTOF | splash10-0a4i-9600000000-f2203fdee1740d3dfdf5 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Methylhistamine 40V, Positive-QTOF | splash10-053u-9000000000-c2f15f4413986661cc69 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Methylhistamine 10V, Negative-QTOF | splash10-001i-9200000000-c93d45eb9945e770c096 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Methylhistamine 20V, Negative-QTOF | splash10-00xr-9400000000-9025f6ff1a1ed56a4d04 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Methylhistamine 40V, Negative-QTOF | splash10-00kf-9000000000-822ca0512145b152290d | 2021-10-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
|---|